The National Health Service has long been a source of British pride, a system designed to be free at the point of use and there for everyone from birth to old age. Yet beneath this proud exterior, a silent and deeply troubling shift is taking place. A growing number of people across the UK are consciously deciding to skip doctor visits, ignore worrying symptoms, and postpone vital medical care. This isn’t happening because they are careless or because they don't value their health. It is happening because of a brutal one-two punch: the rising personal financial cost of seeking care, and the seemingly endless, exhausting delays built into the system itself. Understanding why people are stepping back from the NHS is not merely an academic exercise; it is essential knowledge that directly affects the safety and wellbeing of every household in the country. From the family finances stretched thin by prescription fees to the anxious months spent waiting for a specialist to confirm a diagnosis, these barriers are reshaping the health of a nation in real-time.
The sheer scale of the problem is staggering. Recent polling from the Health Foundation and Ipsos, conducted at the end of 2025, reveals that almost half of people in the UK (48%) delayed or avoided contacting their GP about a health concern in the past year. This isn’t a niche issue affecting a small, disengaged minority; it is a mainstream behaviour pattern that has become normalised across society. When people do not seek help, they do so for a complex mix of reasons, but the dominant themes are cost and access. Among those who avoided their GP, 27% chose to simply manage the problem themselves or wait for symptoms to resolve, effectively hoping for the best. Another 30% did not believe they would be offered a suitable appointment, while 17% felt it would be too difficult to even contact their practice in the first place. This data paints a picture of a public that is not just frustrated, but also fatalistic. People are giving up on the system before they have even tried to engage with it, a decision that carries profound implications for early diagnosis and preventative care.
The connection between this trend and daily life is direct and alarming. When people delay seeing a doctor, minor issues escalate into major crises. A persistent cough that could have been a simple infection becomes pneumonia; a small, unusual mole that could have been easily removed becomes a life-threatening melanoma. In fact, new research has found that 29% of adults have postponed seeking medical help because of extended waiting times, and a shocking 22% have completely avoided consulting a healthcare professional altogether. Worryingly, one in five people delayed visiting their GP despite spotting potential signs of cancer. This is not just about convenience; it is about mortality. NHS figures show that more than a third of melanomas are discovered through routine pathways rather than urgent referrals, meaning that delays in those queues could be hiding a significant number of undiagnosed cancers. For those who do eventually seek care, the journey is often a nightmare of bureaucracy and lost paperwork. Research from Healthwatch England found that one in seven patients (14%) have been stuck in a GP referral "black hole," where their referral to a specialist was delayed, lost, rejected, or never even sent. Seven in ten of these patients only discovered they weren’t on a waiting list after chasing the NHS themselves. The anxiety, pain, and deteriorating health that results from these systemic failures are immeasurable, affecting people’s ability to work, care for their families, and simply live without constant worry.
Perhaps the most paradoxical driver of this avoidance is cost. The NHS is built on the principle of being free at the point of use, but the reality for many is a minefield of hidden expenses that accumulate quickly. A landmark 2025 survey by the Health Foundation found that one in four UK adults (26%) have delayed seeking NHS medical care or prescriptions in the past year due to concerns about associated costs, a sharp increase from 18% just two years prior. For those living on the financial edge, every aspect of seeking care carries a price tag. In England, prescription charges are currently frozen at £9.90 per item, but for someone managing multiple chronic conditions, this can amount to a significant monthly expense. Travel costs to appointments, including notoriously expensive hospital parking fees that can exceed £20 for a single visit, are a real deterrent. For the self-employed, freelancers, or those on precarious zero-hour contracts, taking time off for a doctor's appointment means losing a day’s pay, a decision that can be the difference between paying a bill or not. A survey by Healthwatch Sefton in 2025 found that 34% of residents had already started avoiding the dentist due to cost, 20% had stopped buying over-the-counter medication they normally relied on, and 10% had skipped an NHS appointment because they couldn’t afford the travel. These are not choices made by the wealthy or the indifferent; they are desperate trade-offs made by people trying to survive.
The cost pressures extend beyond direct fees and are infiltrating the very decisions people make about their treatment. A new survey exploring medication, cost and safety in the UK reveals a troubling shift: almost seven in ten Britons would consider choosing a less rigorously tested medication if the price was right. While 47% say they would always choose a safe, rigorously tested medication over a cheaper alternative, 40% say they would usually choose the safer option unless the cost difference was significant. Over one in five people say a 20% saving would be enough for them to choose a less rigorously tested medicine, a figure that rises to one in three for a 30% saving, and one in two for a 50% saving. Overall, almost 68% would consider a less rigorously tested product at some level of discount. This willingness to compromise on safety for financial reasons is a stark indicator of how the cost-of-living crisis is eroding health standards. People are being forced to become amateur pharmacologists, weighing the risk of unknown side effects against the certainty of emptying their wallet. The psychological toll of these decisions is immense, adding another layer of stress to an already overburdened population.
The other half of the deadly duo, NHS delay, is equally corrosive. Waiting times for GP appointments have reached crisis levels. In November 2025 alone, 1.77 million people waited over a month for a GP appointment in England, an increase of nearly 250,000 since July of the same year. Over the autumn period, a staggering 7.6 million patients had to wait more than four weeks to see a GP, up by more than 300,000 from the previous year. 2025 looks set to have the longest waits for a GP appointment since records began five years ago. For those who do manage to secure a referral, the situation often worsens. The total number of people waiting for consultant-led elective care in England continues to hover at historic highs, exceeding 7.5 million treatment pathways. Over 1.5 million people are currently waiting for crucial diagnostic tests like MRIs and CT scans, creating a bottleneck that delays diagnoses for potentially life-threatening conditions. A report from the Public Accounts Committee found that nearly 192,000 patients were waiting over a year for care by July 2025, a length of wait that should have been eliminated by March of that year. For diagnostic tests, 22% of patients were on a waiting list for more than six weeks, far above the operational standard of just 1%. These aren’t just statistics; they represent real people spending months in pain, unable to work, uncertain about their future, and watching their health deteriorate while they wait for answers.
The consequences of this avoidance are not abstract; they are already manifesting in a more sickly and financially insecure population. The delays themselves create a staggering financial burden. Analysis reveals that for a cohort of just 1,000 patients, NHS delays can create an additional financial fallout of over £4.2 million, composed of lost income from being too unwell to work, the spiralling costs of seeking private care out of desperation, and the long-term expense of conditions that worsen while waiting. Projections indicate that as many as two in five Britons may now face significant delays for consultations, diagnostics, and treatments within the NHS. This is a crisis of access that is feeding a crisis of health. People who would have once been treated early and effectively are now slipping through the cracks, only to present later with more advanced, more expensive, and harder-to-treat conditions. The NHS, already stretched to its limit, then faces even greater demands, creating a vicious cycle of backlog and avoidance.
For the average person going about their daily life, this issue is already a constant, grinding presence. It affects decisions about whether to take a new job that doesn’t offer private health insurance, whether to move to a new area with unknown GP access, and whether to ignore that nagging pain until it becomes unbearable. It influences how parents plan for their children’s health, how the elderly manage their chronic conditions, and how the economically vulnerable ration their own care. The cost-of-living crisis and NHS delays are not separate issues; they are intertwined forces that are reshaping the health landscape of the UK. Understanding this connection is the first step in navigating a system that, for many, is no longer functioning as intended. The data is clear: millions are being priced out of or delayed away from the care they need, and the human cost is mounting every single day.